CLINICAL SIGNS OF CHEMOTHERAPY-INDUCED NEUROPATHY IN CANCER PATIENTS AND PHARMACOTHERAPY CORRECTION OPTIONS

by I. A. Zolotovskayaia, I. L. Davydkin, T. M. Lokshtanova, A. E. Orlov
Published 2018-03-01

A Mathematical Model for Complete Morphological Regression in Primary Operable HER2-Positive Breast Cancer

by A. E. Orlov, O. I. Kaganov, V. N. Saveliev, M. V. Tkachev, A. P. Borisov, P. L. Kruglova
Published 2021-04-01

Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor...

by M A Frolova, Ya I Kochetkova, V A Chubenko, N M Volkov, F V Moiseenko, T V Garmarnik, D M Ponomarenko, A E Orlov, Yu V Kostalanova, Yu Yu Makarycheva, A A Nizegorodzeva
Published 2018-06-01